
U.S. Artificial Intelligence in Manufacturing Market Size, Share, Trends, Industry Analysis Report By Component (Hardware, Software), By Technology, By Application, By End Use – Market Forecast, 2025–2034
Description
The U.S. artificial intelligence (AI) in manufacturing market size is expected to reach USD 89.98 billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Artificial Intelligence in Manufacturing Market Size, Share, Trends, Industry Analysis Report By Component (Hardware, Software), By Technology, By Application, By End Use – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
AI in manufacturing refers to the use of artificial intelligence technologies such as machine learning platform, computer vision, and robotics to optimize production processes, improve quality control, and reduce downtime. It enables predictive maintenance, real-time monitoring, and automated decision-making across supply chains and factory operations.
Rising labor costs and a shortage of skilled workers in the U.S. manufacturing sector are prompting companies to invest in AI-driven automation. AI helps fill critical labor gaps by taking over repetitive or dangerous tasks, improving workplace safety and productivity. At the same time, AI-powered systems improve the effectiveness of existing workers by providing real-time data and decision support. This shift is particularly important in regions with aging workforces or where talent is hard to find. AI offers a practical and scalable solution to maintain output without compromising quality or safety as labor challenges persist, thereby driving the growth.
The U.S. manufacturers are prioritizing supply chain resilience and reshoring efforts following disruptions caused by the COVID-19 pandemic and geopolitical tensions. AI plays a critical role in this shift by improving supply chain visibility, predicting demand fluctuations, and optimizing logistics. Manufacturers are using AI to monitor real-time inventory, automate procurement decisions, and adapt quickly to external shocks. These capabilities are essential for creating agile, responsive supply chains that support local production. The national focus on economic resilience, combined with the need for just-in-time efficiency, makes AI a strategic tool in rebuilding and strengthening U.S.-based manufacturing operations, thereby fueling the adoption of AI in manufacturing.
U.S. Artificial Intelligence in Manufacturing Market Report Highlights
The hardware segment led the U.S. market in 2024, driven by increasing demand for high-performance computing systems, AI-enabled sensors, and robotics to enhance manufacturing efficiency and automation.
The computer vision segment witness notable growth in 2024, propelled by the rising need for intelligent visual inspection, real-time safety monitoring, and image-based analytics in key industries such as automotive, aerospace, and food manufacturing.
The production planning segment is expected to grow significantly as manufacturers prioritize agility and operational efficiency in response to changing consumer preferences, labor constraints, and persistent supply chain disruptions.
The medical devices segment accounted for the largest market share in 2024. The dominance is supported by the country’s advanced healthcare sector, strong innovation ecosystem, and strict regulatory requirements that emphasize precision, reliability, and compliance in manufacturing.
A few key players in the U.S. AI in manufacturing market are Microsoft Corporation; Mitsubishi Electric Corporation; NVIDIA Corporation; Oracle Corporation; Rethink Robotics; Rockwell Automation Inc; SAP SE; Siemens AG; Sight Machine; and Spark Cognition Inc.
Polaris Market Research has segmented the U.S. artificial intelligence in manufacturing market report based on component, technology, application, and end use:
By Component (Revenue - USD Billion, 2020–2034)
Hardware
Software
Services
By Technology (Revenue - USD Billion, 2020–2034)
Machine Learning (ML)
Computer Vision
Context Awareness
Natural Language Processing
By Application (Revenue - USD Billion, 2020–2034)
Material Movement
Predictive Maintenance & Machinery Inspection
Production Planning
Field Services
Quality Control & Reclamation
Others
By End Use (Revenue - USD Billion, 2020–2034)
Semiconductor & Electronics
Energy & Power
Medical devices
Automobile
Heavy Metal & Machine Manufacturing
Others
AI in manufacturing refers to the use of artificial intelligence technologies such as machine learning platform, computer vision, and robotics to optimize production processes, improve quality control, and reduce downtime. It enables predictive maintenance, real-time monitoring, and automated decision-making across supply chains and factory operations.
Rising labor costs and a shortage of skilled workers in the U.S. manufacturing sector are prompting companies to invest in AI-driven automation. AI helps fill critical labor gaps by taking over repetitive or dangerous tasks, improving workplace safety and productivity. At the same time, AI-powered systems improve the effectiveness of existing workers by providing real-time data and decision support. This shift is particularly important in regions with aging workforces or where talent is hard to find. AI offers a practical and scalable solution to maintain output without compromising quality or safety as labor challenges persist, thereby driving the growth.
The U.S. manufacturers are prioritizing supply chain resilience and reshoring efforts following disruptions caused by the COVID-19 pandemic and geopolitical tensions. AI plays a critical role in this shift by improving supply chain visibility, predicting demand fluctuations, and optimizing logistics. Manufacturers are using AI to monitor real-time inventory, automate procurement decisions, and adapt quickly to external shocks. These capabilities are essential for creating agile, responsive supply chains that support local production. The national focus on economic resilience, combined with the need for just-in-time efficiency, makes AI a strategic tool in rebuilding and strengthening U.S.-based manufacturing operations, thereby fueling the adoption of AI in manufacturing.
U.S. Artificial Intelligence in Manufacturing Market Report Highlights
The hardware segment led the U.S. market in 2024, driven by increasing demand for high-performance computing systems, AI-enabled sensors, and robotics to enhance manufacturing efficiency and automation.
The computer vision segment witness notable growth in 2024, propelled by the rising need for intelligent visual inspection, real-time safety monitoring, and image-based analytics in key industries such as automotive, aerospace, and food manufacturing.
The production planning segment is expected to grow significantly as manufacturers prioritize agility and operational efficiency in response to changing consumer preferences, labor constraints, and persistent supply chain disruptions.
The medical devices segment accounted for the largest market share in 2024. The dominance is supported by the country’s advanced healthcare sector, strong innovation ecosystem, and strict regulatory requirements that emphasize precision, reliability, and compliance in manufacturing.
A few key players in the U.S. AI in manufacturing market are Microsoft Corporation; Mitsubishi Electric Corporation; NVIDIA Corporation; Oracle Corporation; Rethink Robotics; Rockwell Automation Inc; SAP SE; Siemens AG; Sight Machine; and Spark Cognition Inc.
Polaris Market Research has segmented the U.S. artificial intelligence in manufacturing market report based on component, technology, application, and end use:
By Component (Revenue - USD Billion, 2020–2034)
Hardware
Software
Services
By Technology (Revenue - USD Billion, 2020–2034)
Machine Learning (ML)
Computer Vision
Context Awareness
Natural Language Processing
By Application (Revenue - USD Billion, 2020–2034)
Material Movement
Predictive Maintenance & Machinery Inspection
Production Planning
Field Services
Quality Control & Reclamation
Others
By End Use (Revenue - USD Billion, 2020–2034)
Semiconductor & Electronics
Energy & Power
Medical devices
Automobile
Heavy Metal & Machine Manufacturing
Others
Table of Contents
126 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Europe Subcutaneous Immunoglobulin Market Insights
- 4.1. Europe Subcutaneous Immunoglobulin Market – Market Snapshot
- 4.2. Europe Subcutaneous Immunoglobulin Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Aging Population and Rising Chronic Disease Burden
- 4.2.1.2. Innovation in SCIG Formulations and Drug Delivery Technologies
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Limited plasma supply and sourcing challenges
- 4.2.3. Public opinion and privacy legal precedents
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Europe Subcutaneous Immunoglobulin Market Trends
- 4.6. Value Chain Analysis
- 5. Europe Subcutaneous Immunoglobulin Market, By Product Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Europe Subcutaneous Immunoglobulin Market, By Product Type, by Country, 2020–2034 (USD Billion)
- 5.3. IgG
- 5.3.1. Europe Subcutaneous Immunoglobulin Market, by IgG, by Country, 2020–2034 (USD Billion)
- 5.4. IgA
- 5.4.1. Europe Subcutaneous Immunoglobulin Market, by IgA, by Country, 2020–2034 (USD Billion)
- 5.5. IgM
- 5.5.1. Europe Subcutaneous Immunoglobulin Market, by IgM, by Country, 2020–2034 (USD Billion)
- 6. Europe Subcutaneous Immunoglobulin Market, By Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Europe Subcutaneous Immunoglobulin Market, By Application, by Country, 2020–2034 (USD Billion)
- 6.3. Primary Immunodeficiency Disease
- 6.3.1. Europe Subcutaneous Immunoglobulin Market, by Primary Immunodeficiency Disease, by Country, 2020–2034 (USD Billion)
- 6.4. Secondary Immunodeficiency Disease
- 6.4.1. Europe Subcutaneous Immunoglobulin Market, by Secondary Immunodeficiency Disease, by Country, 2020–2034 (USD Billion)
- 7. Europe Subcutaneous Immunoglobulin Market, By End Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Europe Subcutaneous Immunoglobulin Market, By End Use, by Country, 2020–2034 (USD Billion)
- 7.3. Hospitals
- 7.3.1. Europe Subcutaneous Immunoglobulin Market, by Hospitals, by Country, 2020–2034 (USD Billion)
- 7.4. Homecare
- 7.4.1. Europe Subcutaneous Immunoglobulin Market, by Homecare, by Country, 2020–2034 (USD Billion)
- 7.5. Clinics
- 7.5.1. Europe Subcutaneous Immunoglobulin Market, by Clinics, by Country, 2020–2034 (USD Billion)
- 7.6. Others
- 7.6.1. Europe Subcutaneous Immunoglobulin Market, by Others, by Country, 2020–2034 (USD Billion)
- 8. Europe Subcutaneous Immunoglobulin Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Europe Subcutaneous Immunoglobulin Market Assessment, By Geography, by Country, 2020-2034 (USD Billion)
- 8.3. Europe Subcutaneous Immunoglobulin Market – Europe
- 8.3.1. Europe: Subcutaneous Immunoglobulin Market, by Product Type, by Country, 2020-2034 (USD Billion)
- 8.3.2. Europe: Subcutaneous Immunoglobulin Market, by Application, by Country, 2020-2034 (USD Billion)
- 8.3.3. Europe: Subcutaneous Immunoglobulin Market, by End Use, by Country, 2020-2034 (USD Billion)
- 8.3.4. Europe Subcutaneous Immunoglobulin Market – UK
- 8.3.4.1. UK: Europe Subcutaneous Immunoglobulin Market, by Product Type, by Country, 2020-2034 (USD Billion)
- 8.3.4.2. UK: Europe Subcutaneous Immunoglobulin Market, by Application, by Country, 2020-2034 (USD Billion)
- 8.3.4.3. UK: Europe Subcutaneous Immunoglobulin Market, by End Use, by Country, 2020-2034 (USD Billion)
- 8.3.5. Europe Subcutaneous Immunoglobulin Market – France
- 8.3.5.1. France: Europe Subcutaneous Immunoglobulin Market, by Product Type, by Country, 2020-2034 (USD Billion)
- 8.3.5.2. France: Europe Subcutaneous Immunoglobulin Market, by Application, by Country, 2020-2034 (USD Billion)
- 8.3.5.3. France: Europe Subcutaneous Immunoglobulin Market, by End Use, by Country, 2020-2034 (USD Billion)
- 8.3.6. Europe Subcutaneous Immunoglobulin Market – Germany
- 8.3.6.1. Germany: Europe Subcutaneous Immunoglobulin Market, by Product Type, by Country, 2020-2034 (USD Billion)
- 8.3.6.2. Germany: Europe Subcutaneous Immunoglobulin Market, by Application, by Country, 2020-2034 (USD Billion)
- 8.3.6.3. Germany: Europe Subcutaneous Immunoglobulin Market, by End Use, by Country, 2020-2034 (USD Billion)
- 8.3.7. Europe Subcutaneous Immunoglobulin Market – Italy
- 8.3.7.1. Italy: Europe Subcutaneous Immunoglobulin Market, by Product Type, by Country, 2020-2034 (USD Billion)
- 8.3.7.2. Italy: Europe Subcutaneous Immunoglobulin Market, by Application, by Country, 2020-2034 (USD Billion)
- 8.3.7.3. Italy: Europe Subcutaneous Immunoglobulin Market, by End Use, by Country, 2020-2034 (USD Billion)
- 8.3.8. Europe Subcutaneous Immunoglobulin Market – Spain
- 8.3.8.1. Spain: Europe Subcutaneous Immunoglobulin Market, by Product Type, by Country, 2020-2034 (USD Billion)
- 8.3.8.2. Spain: Europe Subcutaneous Immunoglobulin Market, by Application, by Country, 2020-2034 (USD Billion)
- 8.3.8.3. Spain: Europe Subcutaneous Immunoglobulin Market, by End Use, by Country, 2020-2034 (USD Billion)
- 8.3.9. Europe Subcutaneous Immunoglobulin Market – Netherlands
- 8.3.9.1. Netherlands: Europe Subcutaneous Immunoglobulin Market, by Product Type, by Country, 2020-2034 (USD Billion)
- 8.3.9.2. Netherlands: Europe Subcutaneous Immunoglobulin Market, by Application, by Country, 2020-2034 (USD Billion)
- 8.3.9.3. Netherlands: Europe Subcutaneous Immunoglobulin Market, by End Use, by Country, 2020-2034 (USD Billion)
- 8.3.10. Europe Subcutaneous Immunoglobulin Market – Russia
- 8.3.10.1. Russia: Europe Subcutaneous Immunoglobulin Market, by Product Type, by Country, 2020-2034 (USD Billion)
- 8.3.10.2. Russia: Europe Subcutaneous Immunoglobulin Market, by Application, by Country, 2020-2034 (USD Billion)
- 8.3.10.3. Russia: Europe Subcutaneous Immunoglobulin Market, by End Use, by Country, 2020-2034 (USD Billion)
- 8.3.11. Europe Subcutaneous Immunoglobulin Market – Rest of Europe
- 8.3.11.1. Rest of Europe: Subcutaneous Immunoglobulin Market, by Product Type, by Country, 2020-2034 (USD Billion)
- 8.3.11.2. Rest of Europe: Subcutaneous Immunoglobulin Market, by Application, by Country, 2020-2034 (USD Billion)
- 8.3.11.3. Rest of Europe: Subcutaneous Immunoglobulin Market, by End Use, by Country, 2020-2034 (USD Billion)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. ADMA Biologics, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Baxter International Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Biotest AG
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. CSL Behring
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Grifols S.A.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Johnson & Johnson (Omrix Biopharmaceuticals Inc.)
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Kedrion S.p.A
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Octapharma AG
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Pfizer Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Shanghai RAAS Blood Products Co. Ltd.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Takeda Pharmaceutical Company Limited
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.